| CAS No. | 130793-30-5(free acid) |
| Molecular Formula | C22H43O4 |
| Molecular Weight | N/A |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Compared with other compounds in its class, the molecular weight of 394.57 g/mol gives Orlistat Impurity 50 Sodium Salt distinctive chromatographic separation conditions and mass-spectrometry parameter settings.
CATO supplies Orlistat Impurity 50 Sodium Salt (CAS 130793-30-5(free acid)), a pharmacopoeial impurity reference standard (molecular formula C22H43O4Na, MW 394.57 g/mol) used for the identification and quantification of trace impurities in APIs.
Based on its molecular formula C22H43O4Na, Orlistat Impurity 50 Sodium Salt contains a carboxylic acid group, a hydroxyl group, an ether linkage; these features give the compound characteristic functional-group stretching vibrations in infrared spectroscopy. The molecular weight of 394.57 g/mol is directly relevant to the identification of the molecular ion in mass spectrometry. The high carbon-to-hydrogen ratio imparts good lipophilicity, allowing liquid-liquid extraction with non-polar solvents such as n-hexane or ethyl acetate.
This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.
CATO manufactures Orlistat Impurity 50 Sodium Salt under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
| Molecular Formula | C22H43O4 Na |
| Molecular Weight | 394.57 g/mol |
| Purity | ≥95% |
| Storage | Store at room temperature, keep sealed and dry |
| Solubility (reference) | Soluble in chloroform, dichloromethane, ethyl acetate, DMSO |
| Stability | Stable under recommended storage conditions |
| Degree of Unsaturation (DBE) | 1.5 |